Medha Munshi comments on the VADT trial, showing that the cardioprotective effect of intensive glycemic control in patients with type 2 diabetes disappears after 15 years (3:04).
06-26-2018 | Cardiovascular outcomes | Video
06-26-2018 | Cardiovascular outcomes | Video
Medha Munshi comments on the VADT trial, showing that the cardioprotective effect of intensive glycemic control in patients with type 2 diabetes disappears after 15 years (3:04).